Yamaguchi University Center for Reqenerative Medicine Graduate School of Medicine Yamaguchi University
Japanese | SiteMap | Contact
PeerReview System

Yamaguchi University
Graduate School of Medicine

 News

-  "Development of novel treatment for patients with advanced hepatocellular carcinoma -Deferoxamine for advanced hepatocellular carcinoma-."-by Takahiro Yamasaki, M.D., Ph.D., Shuji Terai, M.D., Ph.D., Isao Sakaida, M.D., Ph.D. of Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, appeared in the Best Journal of Medicine, "The New England Journal of Medicineon - August 11, 2011". (Sep. 22, 2011)

- Yamaguchi University (Japanese)

- The New England Journal of Medicine

 

-  "Autologous Bone Marrow Cell infusion therapy (ABMi)", which has been the world’s first developed by Division of Gastroenterology, Graduate School of Medicine, Yamaguchi University, was conducted in Korea for the first time as a joint project between Yamaguchi University and Department of Medicine, Yonsei University in Korea. The achievement of the clinical research was published in paper. (June 6, 2010)

- The achievement of the clinical research conducted in Korea for the first time

- The world’s first conducted achievement of the clinical research

BackNumber
Center for Reqenerative Medicine
Copyright © 2008 Yamaguchi University All Rights Reserved.